Researchers with the Food and Drug Administration concluded after an analysis of the agency’s data that there is an elevated risk of myocarditis in children as young as 12 after taking the Pfizer COVID-19 shot. The researchers looked for safety signals requiring further investigation in their examination of the data from the FDA’s Biologics Effectiveness … Continue reading FDA study finds Pfizer jab elevates myocarditis risk in kids